BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2001
View Archived Issues
Active Biotech discusses progress during 2000
Read More
Nastech reports corporate update
Read More
Ferring initiates optimal drug protocol trial for IVF treatment
Read More
Enrollment complete in Angiotech phase II study of micellar paclitaxel for SPMS
Read More
Millennium begins phase II clinical trial of LDP-341 for treatment of multiple myeloma
Read More
FDA cancels advisory committee review of Xyrem NDA
Read More
BioMarin completes enrollment in clinical trials of MPS-I and MPS-VI treatments
Read More
First clinical study of acyline, a potent and long-acting GnRH antagonist
Read More
High contraceptive potency and excellent safety reported for microemulsion-based vaginal spermicide
Read More
Arglabin-DMA acts as an inhibitor of posttranslational processing of Ras protein
Read More
Cortez Development acquires MoliChem Medicines and changes name
Read More
Genomics collaboration between Pharmagene and Bayer expanded
Read More
Optimal dose range of pentasaccharide factor Xa inhibitor and comparison to LMWH
Read More
CPMP issues positive opinion for new NeoRecormon indication
Read More
New safety data added to Zyvox prescribing information
Read More
VENUS trial results do not support use of early nimodipine in stroke
Read More
Introgen's INGN-241 shows antitumor activity against human melanoma
Read More
GlaxoSmithKline and WHO to develop new treatment for malaria
Read More
Profile of new antiparkinsonian agent SLV-308 up to early clinical studies
Read More
Faulding to market and sell NaPro's paclitaxel in Europe
Read More
Aventis's new vector complexes useful in gene therapy of cancer
Read More
Antitumor phosphoramide compounds designed at Purdue
Read More
New GH secretagogues in development at Merck
Read More
Cephalosporins synthesized at Roche and tested for antibacterial activity
Read More
Protein kinase inhibitors and their use in the treatment of cancer presented by Agouron
Read More
Novel Nippon Kayaku compounds inhibit tumor cell proliferation
Read More
Benzazepinones and quinazolines useful for cancer, osteoporosis, etc., according to Roche
Read More
Mochida's factor Xa inhibitors endowed with in vivo anticoagulant activity
Read More